There are many common complications encountered during the treatment of lung cancer. touchRESPIRATORY were delighted to speak with Professor Gerard A. Silvestri (Medical University of South Carolina, Charleston, SC, USA) to learn more around the diagnosis, challenges and management of these complications. ‘Diagnosis and Management of Complications in the Treatment of Lung Cancer.’ was presented […]

We were delighted to speak to Dr. Vijay Balasubramanian (UCSF Fresno, Fresno, CA, USA) to learn more around the interim analysis of the EXPEDITE study (ClinicalTrials.gov Identifier: NCT03497689), which investigated whether a short course of parenteral treprostinil therapy would improve tolerability and dosing of oral treprostinil in patients with pulmonary arterial hypertension (PAH). The abstract […]

Mepolizumab is currently approved for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) at a dose of 300mg. touchRESPIRATORY caught up with Dr. Ozge Can Bostan (Hacettepe University School of Medicine, Ankara, Turkey) to discuss the 1 year findings from her study investigating the sinonasal and respiratory outcomes of a low dose of mepolizumab (100 […]

touchRESPIRATORY were delighted to speak with Prof. David Au (University of Washington, Seattle, WA, USA) to discuss the findings from the INSIGHT COPD study, investigating a lifestyle intervention in overweight patients with COPD. ‘Intervention Study in Overweight Patients with COPD (INSIGHT COPD): A Pulmonary Trials Cooperative Randomized Clinical Trial.‘ was presented at ATS 2022, 13-18 […]

Paediatric sleep-disordered breathing (SDB) refers to a spectrum of respiratory disorders with intermittent upper-airway obstruction and sleep disruption in children.1 SDB spans primary snoring, upper-airway resistance syndrome, obstructive hypoventilation and obstructive sleep apnoea (OSA), listed in order of increasing severity of SDB stratified by polysomnography.2 Paediatric OSA is characterized by recurring episodes of airway obstruction, which […]

With the advent of newer drugs targeting the biochemical pathways that lead to cough, it is increasingly important to understand the definition, pathogenesis and management of this symptom. Several specialist bodies also recognize the need for guidance in this area, and the American College of Chest Physicians (ACCP) and European Respiratory Society (ERS) have both […]

Coronavirus is a family of enveloped RNA viruses that include the original SARS coronavirus (SARS-CoV) and the recently emerged SARS-CoV-2. According to the World Health Organization, there have been over 500 million confirmed SARS-CoV-2 infections, and well over 6 million deaths from coronavirus disease 2019 (COVID-19).1 Although the recovery rate from COVID-19 is estimated to be […]

Asthma affects around 339 million people worldwide,1 with approximately 10% of these experiencing severe disease.2 Despite many advances in asthma therapy in recent years, including the advent of biologic therapies, many patients with severe asthma cannot control their symptoms.2,3 Severe, uncontrolled asthma is extremely debilitating and involves frequent exacerbations, significant limitations on lung function and a reduced quality […]